Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17873178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: NI group

Indicates status has not been verified in more than two years